Participate in the Fundamental crowdfunding campaign and support the groundbreaking research that leading scientists are doing to treat end-of-life anxiety, addiction, PTSD and brain cognition with psychedelic assisted therapies.

Fundamental’s first campaign is aimed at funding the research of 4 specific studies: End-of-life anxiety, alcoholism, PTSD, and brain cognition. 

Fundamental was conceived by Rodrigo Niño, a New York-based real estate developer who traveled to Peru to try ayahuasca after being diagnosed with melanoma. 

Wired reports: 

“Right after my first session—my ceremony, they call it—I was completely off my fear of dying,” Niño says. “Completely gone, you know. And then I had to know if what had happened to me was placebo effect caused by the hallucinations, or if in fact I had been physiologically cured.”Problem is, you can’t just call up the federal government and ask for some money, pretty please, to test a schedule 1 drug on people. And good luck getting pharmaceutical companies interested in natural drugs they can’t slap a patent on. “The issue is that [psychedelics] don’t make money, and because they don’t make money traditional capital sources have no interest in them,” says Niño. And so Niño founded Fundamental to take psychedelics research to the people.

“Right after my first session—my ceremony, they call it—I was completely off my fear of dying,” Niño says. “Completely gone, you know. And then I had to know if what had happened to me was placebo effect caused by the hallucinations, or if in fact I had been physiologically cured.”

Problem is, you can’t just call up the federal government and ask for some money, pretty please, to test a schedule 1 drug on people. And good luck getting pharmaceutical companies interested in natural drugs they can’t slap a patent on. “The issue is that [psychedelics] don’t make money, and because they don’t make money traditional capital sources have no interest in them,” says Niño. And so Niño founded Fundamental to take psychedelics research to the people.

It works like this: Anyone can donate money through the fund-raising website CrowdRise, specifying what kind of psychedelics research they want to fund. This money lands in a fund operated by a grantmaking organization called Charities Aid Foundation America that then vets which researchers it doles out the money to. Niño’s aiming for $2 million initially, with the possibility of additional campaigns in the future.

One of the first beneficiaries of the fund will be Amanda Feilding, a legendary figure in the psychedelics movement and, as it happens, a full-blown countess with the most proper British accent you ever did hear. The UN made a terrible mistake, she says, when in 1961 it passed the Single Convention on Narcotic Drugs, essentially Just Say No to Drugs in treaty form. “What we’ve been trying to do for the last 20 years,” Feilding says, “is provide governments and the UN with the scientific evidence so that they can amend or withdraw the conventions prohibiting these substances or lower them from schedule 1 to schedule 3 or 4 so that doctors can prescribe them and research can be done.” To do that, though, she’s relied on donations from individuals or grants from other institutions.

Read more on Wired.